Phase 2 trial of concurrent 5‐fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity‐modulated radiation therapy for locally advanced head and neck cancer von Kao, Johnny, Genden, Eric M., Gupta, Vishal, Policarpio, Edelweiss L., Burri, Ryan J., Rivera, Michael, Gurudutt, Vivek, Som, Peter M., Teng, Marita, Packer, Stuart H.

Volltext